Back

First time evaluation of myocardium microRNA profile in Anderson-Fabry disease: implications in the pathological processes

30 August 2024 (16:00 - 16:50)
Organised by: Logo
Congress Presentation Part of: Non-coding RNA control of cardiovascular diseases Cardiomyopathies ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Costantina Catalano

S. Orsola-Malpighi Policlinic, Bologna (Italy)

6 More presentations in this session

Presentation thumbnail
MicroRNA-145-5p restricts cardiac scar resolution during cardiac regeneration
Doctor H. Wang (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Direct in vivo cardiac reprogramming with circular RNA of single transcription factor delivered by fibroblast-targeting lipid nanoparticles
Mr Q. Wang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
The implantation of a left ventricular assist device causes changes in the aortic miRNome and proteome - an integrative analysis
Miss S. Chytilova (Praggue, CZ)
Abstract Slides
Presentation thumbnail
Inhibition of microRNA-181c-5p rescues diabetes-impaired angiogenesis through activation of key mediators of angiogenesis, cell survival and novel genes, elmo3 and trib1
Doctor E. Solly (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Investigating N6-methyladenosin RNA modification as a mediator of microRNA mechanical regulation in the heart
Professor C. Emanueli (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Non-coding RNA control of cardiovascular diseases

The Event

Event poster

ESC Congress 2024

30 August 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Anderson-Fabry disease patients with anatomical heart hypertrophy express a higher degree of electrocardiographic hypertrophy compared to hypertrophic cardiomyopathy patients
thumbnail
Congress Presentation
T2 mapping as a marker of active myocardial injury in Anderson-Fabry disease patients
thumbnail
Congress Presentation
The spectrum of hypertrophic cardiomyopathies: where is fabry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources